Evaluating the impact of hippocampal sparing during whole brain radiotherapy on neurocognitive functions: A preliminary report of a prospective phase II study

Abstract

Background: Whole brain radiotherapy (WBRT) is the treatment of choice for patients with brain metastases. However, neurocognitive functions (NCFs) decline due to impaired hippocampal neurogenesis might occur thereafter. It is hypothesized that conformal hippocampal avoidance during the course of WBRT (HA-WBRT) might provide meaningful NCF preservation. Our study aims to demonstrate the impact of delivering HA-WBRT on NCF changes in patients receiving WBRT. Methods:Twenty-five patients who were referred for prophylactic cranial irradiation (PCI) or treating oligometastatic brain disease were enrolled in the study. Before the HA-WBRT course, all participants should receive baseline neurocognitive assessment, including memory, executive functions, and psychomotor speed. The primary endpoint was delayed recall, as determined by the change/decline in verbal memory [Wechsler Memory Scale -3 rd edition (WMS III)-Word List score] from the baseline assessment to 4 months after the start of HA-WBRT. Results:Only three patients belonged to the clinical setting of PCI; the remaining 22 patients had oligometastatic brain disease. Regarding neurocognitive outcomes, no statistically significant differences were found between various NCF scores obtained at baseline and at post-radiotherapy intervals, in immediate verbal memory and non-verbal memory, except for delayed recall memory on Word List (F = 5.727, p = 0.048). Conclusions: Functional preservation by hippocampal sparing during WBRT could largely be achieved in this study, which also suggests that HA-WBRT should be a feasible technique preserving neurocognitive functions while maintaining intracranial control. (Biomed J 2015;38:439-449) Key words: brain metastasis, hippocampus, hippocampus avoidance during whole brain radiotherapy, neurocognitive function, whole brain radiotherapy

Prophylactic Cranial Irradiation Following Surgical Resection of Early-Stage Small-Cell Lung Cancer: A Review of the Literature

“…The N -methyl- d -aspartate inhibitor memantine has previously shown to improve neurocognitive side effects from whole-brain radiation therapy for patients with overt metastases ( 21 ). Intensity-modulated radiation therapy has also been employed with hippocampal avoidance specifically for the purpose of improving neurocognition ( 22 , 23 ). These strategies have been combined in NRG Oncology CC-001 with the intent of improving quality of life and cognition for patients receiving prophylactic whole-brain radiation.…”

Perihippocampal metastasis following hippocampus-avoiding prophylactic cranial irradiation for small cell lung cancer: a case report

“…The efficacy of HA-WBRT in reducing NCD has been assessed in prospective clinical trials, 11 , 12 including RTOG 0933, a Phase II multi-institutional study of HA-WBRT (30 Gy in 10 fractions) for patients with BM. 11 The trial included patients with BMs located outside a 5 mm margin around the hippocampus, with a total of 100 patients analyzed.…”

Neurocognitive Effects of Primary Brain Tumors

“…With using IMRT, hippocampus can be localized and hence the dentate gyrus can be spared, resulting in prevention or decrease neurocognitive decline to some extent [121]. Lin et al [122] reported significantly lower rates of memory loss posttreatment and with no treatment-related decline in quality of life with IMRT RT.…”